Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · see citing works

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works

Mild cognitive impairment as a diagnostic entity

Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864 · see citing works

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · see citing works

Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles

Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126 · see citing works

Diffusible, nonfibrillar ligands derived from Aβ _1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · see citing works

Pathways towards and Away from Alzheimer’s Disease

Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052 · see citing works

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668 · see citing works

Amyloid deposition as the central event in the aetiology of Alzheimer’s disease

Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538 · see citing works

Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment: Results From the Cardiovascular Health Study

Lyketsos, C. G., Lopez, O., Jones, B., Fitzpatrick, A. L., Breitner, J., & DeKosky, S. (2002) · JAMA · doi:10.1001/jama.288.12.1475 · Cited by 2,049 · see citing works

Natural oligomers of the amyloid-β protein specifically disrupt cognitive function

Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2004) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,677 · see citing works

Depression and Risk for Alzheimer Disease: Systematic Review, Meta-analysis, and Metaregression Analysis

Ownby, R. L., Crocco, E., Acevedo, A., John, V., & Loewenstein, D. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.5.530 · Cited by 1,493 · see citing works

Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C. A., Hardy, J., Duff, K., Jantzen, P. T., DiCarlo, G., Wilcock, D. M., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,488 · see citing works

Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice

Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L., & LaFerla, F. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.040 · Cited by 1,294 · see citing works

Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline

Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268 · see citing works

Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus

Nibuya, M., Nestler, E., & Duman, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-07-02365.1996 · Cited by 1,206 · see citing works

Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease

Oddo, S. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.012 · Cited by 980 · see citing works

Aph-1, Pen-2, and Nicastrin with Presenilin Generate an Active γ-Secretase Complex

De Strooper, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00205-8 · Cited by 965 · see citing works

Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers

Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y., Viola, K. L., Lambert, M. P., Velasco, P. T., Bigio, E. H., Finch, C. E., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3432-04.2004 · Cited by 954 · see citing works

Molecular and neuronal substrate for the selective attenuation of anxiety

Löw, K., Crestani, F., Keist, R., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Rülicke, T., Bluethmann, H., Möhler, H., et al. (2000) · Science · doi:10.1126/science.290.5489.131 · Cited by 946 · see citing works

BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders

Mattson, M. P., Maudsley, S., & Martin, B. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.08.001 · Cited by 942 · see citing works

BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease

Phillips, H. S., Hains, J. M., Armanini, M., Laramee, G. R., Johnson, S. A., & Winslow, J. W. (1991) · Neuron · doi:10.1016/0896-6273(91)90273-3 · Cited by 921 · see citing works

Environmental Enrichment Reduces Aβ Levels and Amyloid Deposition in Transgenic Mice

Lazarov, O., Robinson, J., Tang, Y.-P., Hairston, I. S., Korade-Mirnics, Z., Lee, V. M.-Y., Hersh, L. B., Sapolsky, R. M., Mirnics, K., & Sisodia, S. S. (2005) · Cell · doi:10.1016/j.cell.2005.01.015 · Cited by 885 · see citing works

Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics

Selkoe, D. J., & Schenk, D. (2003) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140248 · Cited by 816 · see citing works

Essential Role for TrkB Receptors in Hippocampus-Mediated Learning

Minichiello, L., Korte, M., Wolfer, D., Kühn, R., Unsicker, K., Cestari, V., Rossi-Arnaud, C., Lipp, H.-P., Bonhoeffer, T., & Klein, R. (1999) · Neuron · doi:10.1016/s0896-6273(00)80853-3 · Cited by 799 · see citing works

Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective

Young, D., Lawlor, P. A., Leone, P., Dragunow, M., & During, M. J. (1999) · Nature Medicine · doi:10.1038/7449 · Cited by 731 · see citing works

Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer’s disease

Peng, S., Wuu, J., Mufson, E. J., & Fahnestock, M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03135.x · Cited by 691 · see citing works

Individual Differences in Trait Anxiety Predict the Response of the Basolateral Amygdala to Unconsciously Processed Fearful Faces

Etkin, A., Klemenhagen, K. C., Dudman, J. T., Rogan, M. T., Hen, R., Kandel, E. R., & Joy Hirsch, C. (2004) · Neuron · doi:10.1016/j.neuron.2004.12.006 · Cited by 679 · see citing works

The Use of the Morris Water Maze in the Study of Memory and Learning

Brandeis, R., Brandys, Y., & Yehuda, S. (1989) · International Journal of Neuroscience · doi:10.3109/00207458909002151 · Cited by 667 · see citing works

Positron emission tomography in Alzheimer's disease

Duara, R., Grady, C., Haxby, J. V., Sundaram, M., Cutler, N. R., Heston, L. L., Moore, A., Schlageter, N. L., Larson, S., & Рапопорт, С. И. (1986) · Neurology · doi:10.1212/wnl.36.7.879 · Cited by 568 · see citing works

Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation: Reversibility by drugs that enhance cAMP signaling

Vitolo, O. V., Sant'Angelo, A., Costanzo, V., Battaglia, F., Arancio, O., & Shelanski, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172504199 · Cited by 534 · see citing works

Region-Specific Neurotrophin Imbalances in Alzheimer Disease: Decreased Levels of Brain-Derived Neurotrophic Factor and Increased Levels of Nerve Growth Factor in Hippocampus and Cortical Areas

Hock, C., Heese, K., Hulette, C., Rosenberg, C., & Otten, U. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.846 · Cited by 523 · see citing works

Serotonin in Aging, Late-Life Depression, and Alzheimer's Disease: The Emerging Role of Functional Imaging

MELTZER, C. C. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00194-2 · Cited by 517 · see citing works

Neocortical Neurofibrillary Tangles Correlate With Dementia Severity in Alzheimer's Disease

Bierer, L. M., Hof, P. R., Purohit, D. P., Carlin, L., Schmeidler, J., Davis, K. L., & Perl, D. P. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540250089017 · Cited by 514 · see citing works

E PIDEMIOLOGY OF N EURODEGENERATION

Mayeux, R. P. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.043002.094919 · Cited by 511 · see citing works

cAMP Response Element-Mediated Gene Transcription Is Upregulated by Chronic Antidepressant Treatment

Thome, J., Sakai, N., Shin, K.-H., Steffen, C., Zhang, Y.-J., Impey, S., Storm, D. R., & Duman, R. S. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04030.2000 · Cited by 507 · see citing works

Acetylcholine modulation of neural systems involved in learning and memory

Gold, P. E. (2003) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2003.07.003 · Cited by 448 · see citing works

Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice

Duan, W., Guo, Z., Jiang, H., Ware, M., Li, X.-J., & Mattson, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0536856100 · Cited by 428 · see citing works

Reversible memory loss in a mouse transgenic model of Alzheimer’s disease

Kotilinek, L. A., Bacskai, B., Westerman, M., Kawarabayashi, T., Younkin, L., Hyman, B. T., Younkin, S., & Ashe, K. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06331.2002 · Cited by 420 · see citing works

BDNF and Full-length and Truncated TrkB Expression in Alzheimer Disease. Implications in Therapeutic Strategies

Ferrer, I., Marı́n, C., Rey, M. J., Ribalta, T., Goutan, E., Blanco, R., Tolosa, E. S., & Martı́, E. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199907000-00007 · Cited by 407 · see citing works

NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults

Cheng, B., & Mattson, M. P. (1994) · Brain Research · doi:10.1016/0006-8993(94)91857-0 · Cited by 394 · see citing works

Temporal Profile of Amyloid-β (Aβ) Oligomerization in an in Vivo Model of Alzheimer Disease

Oddo, S., Caccamo, A., Tran, L., Lambert, M. P., Glabe, C. G., Klein, W. L., & LaFerla, F. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507892200 · Cited by 379 · see citing works

New Phosphorylation Sites Identified in Hyperphosphorylated Tau (Paired Helical Filament‐Tau) from Alzheimer's Disease Brain Using Nanoelectrospray Mass Spectrometry

Hanger, D. P., Betts, J. C., Loviny, T. L. F., Blackstock, W. P., & Anderton, B. H. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71062465.x · Cited by 378 · see citing works

Cortical abnormalities in Alzheimer's disease

Foster, N. L., Chase, T. N., Mansi, L., Brooks, R., Fedio, P., Patronas, N. J., & Chiro, G. D. (1984) · Annals of Neurology · doi:10.1002/ana.410160605 · Cited by 378 · see citing works

Regulation of late-phase LTP and long-term memory in normal and aging hippocampus: role of secreted proteins tPA and BDNF

Pang, P. T., & Lu, B. (2004) · Ageing Research Reviews · doi:10.1016/j.arr.2004.07.002 · Cited by 337 · see citing works

Caloric restriction attenuates Aβ-deposition in Alzheimer transgenic models

Patel, N. V., Gordon, M. N., Connor, K. E., Good, R. A., Engelman, R. W., Mason, J., Morgan, D. G., Morgan, T. E., & Finch, C. E. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.09.014 · Cited by 329 · see citing works

Hippocampal innervation by serotonin neurons of the midbrain raphe in the rat

Moore, R. Y., & Halaris, A. E. (1975) · The Journal of Comparative Neurology · doi:10.1002/cne.901640203 · Cited by 321 · see citing works

Caloric restriction attenuates β‐amyloid neuropathology in a mouse model of Alzheimer's disease

Wang, J., Ho, L., Qin, W., Rocher, A. B., Seror, I., Humala, N., Maniar, K. P., Dolios, G., Wang, R., Hof, P. R., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3182fje · Cited by 317 · see citing works

Gender differences in the amount and deposition of amyloidβ in APPswe and PS1 double transgenic mice

Wang, J., Tanila, H., Puoliväli, J., Kadish, I., & Groen, T. V. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.009 · Cited by 316 · see citing works

Testosterone reduces neuronal secretion of Alzheimer's β-amyloid peptides

Gouras, G. K., Xu, H., Gross, R. S., Greenfield, J. P., Hai, B., Wang, R., & Greengard, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1202 · Cited by 300 · see citing works

Relative Roles of Plaques and Tangles in the Dementia of Alzheimer's Disease: Correlations Using Three Sets of Neuropathological Criteria

Nagy, Z., Esiri, M. M., Jobst, K. A., Morris, J. H., King, E. M.-F., McDonald, B., Litchfield, S., Smith, A. D., Barnetson, L. P. D., & Smith, A. D. (1995) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106918 · Cited by 283 · see citing works

Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder

D, M. F. M., Judge, R., HOOG, S. L., Nilsson, M., & Koke, S. C. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1109 · Cited by 266 · see citing works

Learning upregulates brain-derived neurotrophic factor messenger ribonucleic acid: A mechanism to facilitate encoding and circuit maintenance?

Kesslak, J. P., So, V., Choi, J., Cotman, C. W., & Gómez‐Pinilla, F. (1998) · Behavioral Neuroscience · doi:10.1037//0735-7044.112.4.1012 · Cited by 253 · see citing works

Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors

Cryan, J. F., O’Leary, O. F., Jin, S., Friedland, J. C., Ouyang, M., Hirsch, B. R., Page, M. E., Dalvi, A., THOMAS, S. A., & Lucki, I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401080101 · Cited by 252 · see citing works

Bi-phasic change in BDNF gene expression following antidepressant drug treatment

Coppell, A., Pei, Q., & Zetterström, T. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00077-7 · Cited by 241 · see citing works

Progressive and gender-dependent cognitive impairment in the APPSW transgenic mouse model for Alzheimer’s disease

King, D. L., Arendash, G. W., Crawford, F., Sterk, T., Menendez, J., & MULLAN, M. J. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00037-6 · Cited by 227 · see citing works

Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice

Lim, G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00299-8 · Cited by 224 · see citing works

Learning and Memory in Transgenic Mice Modeling Alzheimer's Disease

Ashe, K. H. (2001) · Learning & Memory · doi:10.1101/lm.43701 · Cited by 224 · see citing works

β-Amyloid-(1–42) Impairs Activity-dependent cAMP-response Element-binding Protein Signaling in Neurons at Concentrations in Which Cell Survival Is Not Compromised

Tong, L., Thornton, P. L., Balazs, R., & Cotman, C. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010450200 · Cited by 206 · see citing works

Correlation between cognitive deficits and Aβ deposits in transgenic APP+PS1 mice

Gordon, M. N., King, D. L., Diamond, D. M., Jantzen, P. T., Boyett, K. W., Hope, C. E., Hatcher-Martin, J. M., DiCarlo, G., Gottschall, W. P. E., Morgan, D., et al. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00249-9 · Cited by 199 · see citing works

Reversal of Behavioral and Metabolic Abnormalities, and Insulin Resistance Syndrome, by Dietary Restriction in Mice Deficient in Brain-Derived Neurotrophic Factor

Duan, W., Guo, Z., Jiang, H., Ware, M., & Mattson, M. P. (2003) · Endocrinology · doi:10.1210/en.2002-0113 · Cited by 194 · see citing works

Emotional Memory: In Search of Systems and Synapsesa

LeDoux, J. E. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb17246.x · Cited by 184 · see citing works

Tau gene mutations: dissecting the pathogenesis of FTDP-17

Ingram, E., & Spillantini, M. G. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02440-1 · Cited by 177 · see citing works

Mechanism of Cerebral β-Amyloid Angiopathy: Murine and Cellular Models

Herzig, M. C., Nostrand, W. E. V., & Jucker, M. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2006.tb00560.x · Cited by 167 · see citing works

Noradrenergic and serotonergic blockade inhibits BDNF mRNA activation following exercise and antidepressant

Ivy, A. S., Rodriguez, F. G., Garcia, C., Chen, M. J., & Russo‐Neustadt, A. A. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00044-3 · Cited by 164 · see citing works

Specific spatial learning deficits become severe with age in β-amyloid precursor protein transgenic mice that harbor diffuse β-amyloid deposits but do not form plaques

Koistinaho, M., Ort, M., Cimadevilla, J. M., Vondrous, R., Cordell, B., Koıstınaho, J., Bureš, J., & Higgins, L. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261562998 · Cited by 160 · see citing works

Influence of paroxetine, branched-chain amino acids and tyrosine on neuroendocrine system responses and fatigue in humans

Strüder, H., Hollmann, W., Platen, P., Donike, M., Gotzmann, A., & Weber, K. (1998) · Hormone and Metabolic Research · doi:10.1055/s-2007-978864 · Cited by 147 · see citing works

Amygdala Volume Reductions in Pediatric Patients with Obsessive–Compulsive Disorder Treated with Paroxetine: Preliminary Findings

Szeszko, P. R., MacMillan, S., McMeniman, M., Lorch, E., Madden, R., Ivey, J., Banerjee, S. P., Moore, G. J., & Rosenberg, D. R. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300399 · Cited by 141 · see citing works

Effects of cyclic adenosine monophosphate response element binding protein overexpression in the basolateral amygdala on behavioral models of depression and anxiety

Wallace, T. L., Stellitano, K. E., Neve, R. L., & Duman, R. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.04.010 · Cited by 133 · see citing works

Does my mouse have Alzheimer's disease?

Dodart, J., Mathis, C., Bales, K. R., & Paul, S. M. (2002) · Genes Brain & Behavior · doi:10.1034/j.1601-183x.2002.10302.x · Cited by 125 · see citing works

Neurofibrillary tangles and β-amyloid deposits in Alzheimer's disease

Goedert, M., Sisodia, S. S., & Price, D. L. (1991) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(91)90067-h · Cited by 125 · see citing works

Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms

Lee, J. E., Fukumoto, H., Orne, J. D., Klucken, J., Raju, S., Vanderburg, C. R., Irizarry, M. C., Hyman, B. T., & Ingelsson, M. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.01.026 · Cited by 124 · see citing works

Estrogen induces a rapid secretion of amyloid β precursor protein via the mitogen‐activated protein kinase pathway

Manthey, D., Heck, S., Engert, S., & Behl, C. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02346.x · Cited by 122 · see citing works

Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid β peptide levels

Pacheco‐Quinto, J., Turco, E., DeRosa, S., Howard, A., Cruz-Sánchez, F., Sambamurti, K., Refolo, L. M., Petanceska, S. S., & Pappolla, M. A. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.005 · Cited by 118 · see citing works

Brain-derived neurotrophic factor, behavior, and new directions for the treatment of mental disorders

Russo‐Neustadt, A. A. (2003) · Seminars in Clinical Neuropsychiatry · doi:10.1053/scnp.2003.50014 · Cited by 111 · see citing works

Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer's disease

Murray, K. D., Gall, C. M., Jones, E. G., & Isackson, P. J. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90202-x · Cited by 110 · see citing works

Interactions of Amyloidogenic Proteins

Giasson, B. I., Lee, V. M. ‐., & Trojanowski, J. Q. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:4:1-2:49 · Cited by 106 · see citing works

Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: A single-blind randomised placebo controlled trial

Paile‐Hyvärinen, M., Wahlbeck, K., & Eriksson, J. G. (2003) · BMC Family Practice · doi:10.1186/1471-2296-4-7 · Cited by 106 · see citing works

The mechanisms involved in the long‐lasting neuroprotective effect of fluoxetine against MDMA (‘ecstasy’)‐induced degeneration of 5‐HT nerve endings in rat brain

Sanchez, V., Camarero, J., Esteban, B. M., Peter, M. J., Green, A. R., & Colado, M. I. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704230 · Cited by 103 · see citing works

Amygdala cell loss and atrophy in Alzheimer's disease

Scott, S. A., Sparks, D. L., Scheff, S. W., DeKosky, S. T., & Knox, C. A. (1992) · Annals of Neurology · doi:10.1002/ana.410320412 · Cited by 100 · see citing works

Seizure-induced memory impairment is reduced by choline supplementation before or after status epilepticus

Holmes, G. L., Yang, Y., Liu, Z., Cermak, J. M., Sarkisian, M. R., Stafstrom, C. E., Neill, J. C., & Blusztajn, J. K. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(01)00321-7 · Cited by 100 · see citing works

Serotonin laterality in amygdala predicts performance in the elevated plus maze in rats

Andersen, S. L., & Teicher, M. H. (1999) · Neuroreport · doi:10.1097/00001756-199911260-00006 · Cited by 98 · see citing works

Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatment

Martínez-Turrillas, R., Rı́o, J. D., & Frechilla, D. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.07.006 · Cited by 97 · see citing works

Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: Implications for Alzheimer β-amyloid pathology

Maynard, C. J., Cappai, R., Volitakis, I., Cherny, R. A., Masters, C. L., Li, Q., & Bush, A. I. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.02.010 · Cited by 96 · see citing works

Development of Abeta terminal end-specific antibodies and sensitive ELISA for Abeta variant.

Horikoshi, Y., Sakaguchi, G., Becker, A. G., Gray, A. J., Duff, K., Aisen, P., Yamaguchi, H., Maeda, M., Kinoshita, N., & Matsuoka, Y. (2004) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2004.05.051 · Cited by 95 · see citing works

Paroxetine retards disease onset and progression in Huntingtin mutant mice

Duan, W., Guo, Z., Jiang, H., Ladenheim, B., Xu, X. Z. S., Cadet, J. L., & Mattson, M. P. (2004) · Annals of Neurology · doi:10.1002/ana.20075 · Cited by 91 · see citing works

Sex differences in serotonergic activity in dorsal and median raphe nucleus

DOMINGUEZ, R., Cruz-Morales, S. E., de Carvalho, M. C., Xavier, M., & Brandão, M. L. (2003) · Physiology & Behavior · doi:10.1016/j.physbeh.2003.07.012 · Cited by 70 · see citing works

Functional Neurochemistry of Alzheimers Disease

Gsell, W., Jungkunz, G., & Riederer, P. F. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043386473 · Cited by 70 · see citing works

Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients

Shimabukuro, J., Awata, S., & Matsuoka, H. (2005) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2005.01371.x · Cited by 67 · see citing works

Comparison of the anticholinergic effects of the serotonergic antidepressants, paroxetine, fluvoxamine and clomipramine

Fujishiro, J., Imanishi, T., Onozawa, K., & Tsushima, M. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02557-8 · Cited by 66 · see citing works

GABA-A and 5-HT1A Receptor Agonists Block Expression of Fear-Potentiated Startle in Mice

Risbrough, V. B., Brodkin, J. D., & Geyer, M. A. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300079 · Cited by 56 · see citing works

Affinity Purification of Human τ Proteins and the Construction of a Sensitive Sandwich Enzyme‐Linked Immunosorbent Assay for Human τ Detection

Mercken, M. H., Vandermeeren, M., Lübke, U., Six, J., Boons, J., Vanmechelen, E., VOORDE, A. V. D., & Gheuens, J. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09754.x · Cited by 49 · see citing works

FDA-Preapproved Drugs Targeted to the Translational Regulation and Processing of the Amyloid Precursor Protein

Morse, L. J., Payton, S. M., Cuny, G. D., & Rogers, J. T. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:1:129 · Cited by 47 · see citing works

Pilot Study of the Reducing Effect on Amyloidosis In Vivo by Three FDA Pre-Approved Drugs Via the Alzheimers APP 5Untranslated Region

Tucker, S. C., Ahl, M., Bush, A. I., Westaway, D. A., Huang, X., & Rogers, J. T. (2005) · Current Alzheimer Research · doi:10.2174/1567205053585855 · Cited by 44 · see citing works

Disturbance of the 5-hydroxytryptamine metabolism in brains from patients with Alzheimer’s dementia

Gottfries, C. G. (1990) · Springer eBooks · doi:10.1007/978-3-7091-3345-3_4 · Cited by 44 · see citing works

Toward Alzheimer Therapies Based on Genetic Knowledge

Hardy, J. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.103607 · Cited by 41 · see citing works

Erratum to “Gender differences in the amount and deposition of amyloidβ in APPswe and PS1 double transgenic mice” [Neurobiol. Dis. 14 (2003) 318–327]

Wang, J., Tanila, H., Puoliväli, J. T., Kadish, I., & van Groen, T. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.02.006 · Cited by 34 · see citing works

Spotlight on Paroxetine in Psychiatric Disorders in Adults*

Wagstaff, A. J., Cheer, S. M., Matheson, A. J., Ormrod, D. J., & Goa, K. L. (2002) · CNS Drugs · doi:10.2165/00023210-200216060-00006 · Cited by 31 · see citing works

Restraint stress induces β-amyloid precursor protein mRNA expression in the rat basolateral amygdala

Rosa, M. L. N. M., Guimarães, F. S., de Oliveira, R. M. W., Padovan, C. M., Pearson, R. C. A., & Bel, E. A. D. (2004) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.11.011 · Cited by 25 · see citing works

Evaluation of [3H]paroxetine as an in vivo ligand for serotonin uptake sites: A quantitative autoradiographic study in the rat brain

Biegon, A. R., & Mathis, C. A. (1993) · Synapse · doi:10.1002/syn.890130102 · Cited by 24 · see citing works

Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review

Bourin, M. (2002) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.467 · Cited by 23 · see citing works

Effect of LTP-reinforcing paradigms on neurotransmitter release in the dentate gyrus of young and aged rats

Almaguer‐Melian, W., Cruz-Aguado, R., de la Riva, C., Kendrick, K. M., Frey, J. U., & Bergado, J. A. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.085 · Cited by 23 · see citing works

The amygdala in down's syndrome and familial Alzheimer's disease: Four clinicopathological case report

Murphy, G. M., & Ellis, W. G. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90075-w · Cited by 20 · see citing works

Influence of fluoxetine and paroxetine in behavioral sensitization induced by ethanol in mice

Goeldner, F. O., Pigatto, G., Ribeiro, A. F., Machado, H. B., & Boerngen-Lacerda, R. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.09.009 · Cited by 19 · see citing works

Laterality in the Histological Effects of Injections of Amyloid-β 25-35 into the Amygdala of Young Fischer Rats

Sigurdsson, E. M., Lee, J. M., Dong, X. W., Hejna, M. J., & Lorens, S. A. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199706000-00009 · Cited by 17 · see citing works

Alzheimer's disease: From molecular biology to neuropsychiatry

Cummings, J. L. (2003) · Seminars in Clinical Neuropsychiatry · doi:10.1053/scnp.2003.50005 · Cited by 13 · see citing works

Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex.

Yilmazer‐Hanke, D. (1998) · PubMed · Cited by 9 · see citing works

Clinical and Molecular Aspects of Frontotemporal Dementia

Froelich-Fabre, S., Skoglund, L., Ostojic, J., Kilander, L., Lindau, M. P., Glaser, A., Basun, H., & Lannfelt, L. (2004) · Neurodegenerative Diseases · doi:10.1159/000080989 · Cited by 9 · see citing works

Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models

Webster, S. J., Bachstetter, A. D., Nelson, P. T., Schmitt, F. A., & Van Eldik, L. J. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00088 · Cited by 755 · see citing works

The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease

Amidfar, M., de Oliveira, J., Kucharska, E., Budni, J., & Kim, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118020 · Cited by 412 · see citing works

Acute Kidney Injury Leads to Inflammation and Functional Changes in the Brain

Liu, M., Liang, Y., Chigurupati, S., Lathia, J. D., Pletnikov, M. V., Sun, Z., Crow, M. T., Ross, C. A., Mattson, M. P., & Rabb, H. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007080901 · Cited by 402 · see citing works

Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans

Cirrito, J. R., Disabato, B. M., Restivo, J. L., Verges, D. K., Goebel, W. D., Sathyan, A., Hayreh, D., D'Angelo, G., Benzinger, T., Yoon, H., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107411108 · Cited by 370 · see citing works

A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease

Kashiwaya, Y., Bergman, C., Lee, J.-H., Wan, R., King, M. T., Mughal, M. R., Okun, E., Clarke, K., Mattson, M. P., & Veech, R. L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.023 · Cited by 363 · see citing works

The neurobiology of brain and cognitive reserve: Mental and physical activity as modulators of brain disorders

Nithianantharajah, J., & Hannan, A. J. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.10.001 · Cited by 324 · see citing works

The serotonergic system in ageing and Alzheimer's disease

Rodriguez, J. J., Noristani, H. N., & Verkhratsky, A. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.06.010 · Cited by 266 · see citing works

Modifiable Risk Factors for Alzheimer’s Disease

Edwards III, G. A., Gamez, N., Escobedo Jr., G., Calderon, O., & Moreno-Gonzalez, I. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00146 · Cited by 253 · see citing works

Review: Environmental enrichment and brain repair: harnessing the therapeutic effects of cognitive stimulation and physical activity to enhance experience‐dependent plasticity

Hannan, A. J. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12102 · Cited by 240 · see citing works

Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession

Liu, D., Pitta, M., Jiang, H., Lee, J.-H., Zhang, G., Chen, X., Kawamoto, E. M., & Mattson, M. P. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.020 · Cited by 238 · see citing works

An Antidepressant Decreases CSF Aβ Production in Healthy Individuals and in Transgenic AD Mice

Sheline, Y., West, T., Yarasheski, K., Swarm, R., Jasielec, M. S., Fisher, J. R., Ficker, W. D., Yan, P., Xiong, C., Frederiksen, C., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008169 · Cited by 238 · see citing works

Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer’s disease

Liu, Y., Yoo, M.-J., Savonenko, A., Stirling, W., Price, D. L., Borchelt, D. R., Mamounas, L., Lyons, W. E., Blue, M. E., & Lee, M. K. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4218-08.2008 · Cited by 206 · see citing works

The dorsal raphe nucleus and serotonin: implications for neuroplasticity linked to major depression and Alzheimer's disease

MICHELSEN, K., PRICKAERTS, J., & STEINBUSCH, H. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00912-6 · Cited by 196 · see citing works

Adverse Stress, Hippocampal Networks, and Alzheimer’s Disease

Rothman, S. M., & Mattson, M. P. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8107-9 · Cited by 197 · see citing works

Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemia

Son, T. G., Camandola, S., Arumugam, T. V., Cutler, R. G., Telljohann, R. S., Mughal, M. R., Moore, T. A., Luo, W., Yu, Q., Johnson, D. A., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06552.x · Cited by 190 · see citing works

Activity-dependent, stress-responsive BDNF signaling and the quest for optimal brain health and resilience throughout the lifespan

Rothman, S. M., & Mattson, M. P. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.10.014 · Cited by 183 · see citing works

Impaired Attention in the 3xTgAD Mouse Model of Alzheimer's Disease: Rescue by Donepezil (Aricept)

Romberg, C., Mattson, M. P., Mughal, M. R., Bussey, T. J., & Saksida, L. M. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5242-10.2011 · Cited by 160 · see citing works

Anti-depressant natural flavonols modulate BDNF and beta amyloid in neurons and hippocampus of double TgAD mice

Hou, Y., Aboukhatwa, M. A., Lei, D.-L., Manaye, K. F., Khan, I. A., & Luo, Y. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.11.002 · Cited by 141 · see citing works

Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3xTg-AD)

Filali, M., Lalonde, R., Thériault, P., Julien, C., Calon, F., & Planel, E. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.07.004 · Cited by 139 · see citing works

Major depression, cognitive dysfunction and Alzheimer's disease: Is there a link?

Sierksma, A. S. R., van den Hove, D. L. A., Steinbusch, H. W. M., & Prickaerts, J. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.021 · Cited by 139 · see citing works

Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease

Webster, S. J., Bachstetter, A. D., & Eldik, L. J. V. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt182 · Cited by 140 · see citing works

Nobiletin, a Citrus Flavonoid, Improves Cognitive Impairment and Reduces Soluble Aβ Levels in a Triple Transgenic Mouse Model of Alzheimer’s Disease (3XTg-AD)

Nakajima, A., Aoyama, Y., Shin, E.-J., Nam, Y., Kim, H.-C., Nagai, T., Yokosuka, A., Mimaki, Y., Yokoi, T., Ohizumi, Y., et al. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.04.028 · Cited by 138 · see citing works

TGF‐β1 Pathway as a New Target for Neuroprotection in Alzheimer's Disease

Caraci, F., Battaglia, G., Bruno, V., Bosco, P., Carbonaro, V., Giuffrida, M. L., Drago, F., Sortino, M., Nicoletti, F., & Copani, A. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2009.00115.x · Cited by 129 · see citing works

The putative neurodegenerative links between depression and Alzheimer's disease

Wuwongse, S., Chang, R. C., & Law, A. C. K. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.005 · Cited by 124 · see citing works

Inhibitory effects of SSRIs on IFN-γ induced microglial activation through the regulation of intracellular calcium.

Horikawa, H., Kato, T., Mizoguchi, Y., Monji, A., Seki, Y., Ohkuri, T., Gotoh, L., Yonaha, M., Ueda, T., Hashioka, S., et al. (2010) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.015 · Cited by 113 · see citing works

The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease

Rosenberg, P. B., Mielke, M. M., Han, D., Leoutsakos, J., Lyketsos, C. G., Rabins, P. V., Zandi, P. P., Breitner, J. C. S., Norton, M. C., Welsh-Bohmer, K. A., et al. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3769 · Cited by 117 · see citing works

The KATP Channel Activator Diazoxide Ameliorates Amyloid-β and Tau Pathologies and Improves Memory in the 3xTgAD Mouse Model of Alzheimer's Disease

Liu, D., PITTA, M. G. R., Lee, J.-H., Ray, B., Lahiri, D. K., Furukawa, K., Mughal, M. R., Jiang, H., Villarreal, J. S., Cutler, R. G., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101017 · Cited by 113 · see citing works

Dysfunction of TGF-β1 signaling in Alzheimer’s disease: perspectives for neuroprotection

Caraci, F., Spampinato, S. F., Sortino, M. A., Bosco, P., Battaglia, G., Bruno, V., Drago, F., Nicoletti, F., & Copani, A. (2011) · Cell and Tissue Research · doi:10.1007/s00441-011-1230-6 · Cited by 115 · see citing works

iTRAQ Analysis of Complex Proteome Alterations in 3xTgAD Alzheimer's Mice: Understanding the Interface between Physiology and Disease

Martin, B., Brenneman, R., Becker, K. G., Guček, M., Cole, R. N., & Maudsley, S. R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002750 · Cited by 113 · see citing works

Immunomodulation mechanism of antidepressants: interactions between serotonin/norepinephrine balance and Th1/Th2 balance

Martino, M., Rocchi, G., Escelsior, A., & Fornaro, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604542 · Cited by 111 · see citing works

Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer’s Disease Treatment

Peron, R., Vatanabe, I. P., Manzine, P. R., Camins, A., & Cominetti, M. R. (2018) · Pharmaceuticals · doi:10.3390/ph11010012 · Cited by 111 · see citing works

Molecular imaging of serotonin degeneration in mild cognitive impairment

Smith, G. S., Barrett, F. S., Joo, J. H., Nassery, N., Savonenko, A. V., Sodums, D. J., Marano, C. M., Munro, C. A., Brandt, J., Kraut, M. A., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.05.007 · Cited by 102 · see citing works

Sleep Disturbances in Alzheimer’s and Parkinson’s Diseases

Rothman, S. M., & Mattson, M. P. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8181-2 · Cited by 102 · see citing works

Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical Research

Dennison, J. L., Ricciardi, N. R., Lohse, I., Volmar, C., & Wahlestedt, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201014 · Cited by 100 · see citing works

Amitriptyline-Mediated Cognitive Enhancement in Aged 3×Tg Alzheimer's Disease Mice Is Associated with Neurogenesis and Neurotrophic Activity

Chadwick, W., Mitchell, N., Caroll, J., Zhou, Y., Park, S.-S., Wang, L., Becker, K. G., Zhang, Y., Lehrmann, E., Wood, W. H., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021660 · Cited by 97 · see citing works

The impact of voluntary exercise on mental health in rodents: A neuroplasticity perspective

Pietropaolo, S., Sun, Y., Li, R., Brana, C., Feldon, J., & Yee, B. K. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.03.014 · Cited by 99 · see citing works

Memory formation and retention are affected in adult miR-132/212 knockout mice

Hernandez-Rapp, J., Smith, P. Y., Filali, M., Goupil, C., Planel, E., Magill, S. T., Goodman, R. H., & Hébert, S. S. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.03.032 · Cited by 96 · see citing works

Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing

Fang, J., Pieper, A. A., Nussinov, R., Lee, G., Bekris, L. M., Leverenz, J. B., Cummings, J. L., & Cheng, F. (2020) · Medicinal Research Reviews · doi:10.1002/med.21709 · Cited by 93 · see citing works

Depression and Alzheimer's Disease: Is Stress the Initiating Factor in a Common Neuropathological Cascade?

Aznar, S., & Knudsen, G. M. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100390 · Cited by 93 · see citing works

Prolonged running, not fluoxetine treatment, increases neurogenesis, but does not alter neuropathology, in the 3xTg mouse model of Alzheimer’s disease

Marlatt, M. W., Potter, M. C., Bayer, T. A., van Praag, H., & Lucassen, P. J. (2013) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2012_237 · Cited by 92 · see citing works

A Review: Treatment of Alzheimer’s Disease Discovered in Repurposed Agents

Appleby, B. S., Nacopoulos, D. A., Milano, N. J., Zhong, K., & Cummings, J. L. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000345791 · Cited by 90 · see citing works

Depressive-Like Behavior Is Paired to Monoaminergic Alteration in a Murine Model of Alzheimer's Disease

Romano, A., Pace, L., Tempesta, B., Lavecchia, A. M., Macheda, T., Bedse, G., Petrella, A., Cifani, C., Serviddio, G., Vendemiale, G., et al. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu020 · Cited by 88 · see citing works

Sphingolipids in Alzheimer's disease, how can we target them?

Crivelli, S. M., Giovagnoni, C., Visseren, L., Scheithauer, A.-L., de Wit, N. M., den Hoedt, S., Losen, M. H., Mulder, M. T., Walter, J., de Vries, H. E., et al. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.12.003 · Cited by 85 · see citing works

Selective serotonin reuptake inhibitors and Alzheimer’s disease

Mdawar, B., Ghossoub, E., & Khoury, R. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.264445 · Cited by 75 · see citing works

Altered Brain Serotonin Transporter and Associated Glucose Metabolism in Alzheimer Disease

Ouchi, Y., Yoshikawa, E., Futatsubashi, M., Yagi, S., Ueki, T., & Nakamura, K. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.063008 · Cited by 83 · see citing works

Drug Repositioning Approaches for the Discovery of New Therapeutics for Alzheimer's Disease

Kim, T. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0325-7 · Cited by 82 · see citing works

Pharmacomimetics of Exercise: Novel Approaches for Hippocampally- Targeted Neuroprotective Agents

Stranahan, A. M., Zhou, Y., Martin, B., & Maudsley, S. R. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709789878292 · Cited by 83 · see citing works

Redundant Gs-coupled serotonin receptors regulate amyloid-β metabolism in vivo

Fisher, J. R., Wallace, C. E., Tripoli, D. L., Sheline, Y. I., & Cirrito, J. R. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0112-5 · Cited by 79 · see citing works

Complex and Multidimensional Lipid Raft Alterations in a Murine Model of Alzheimer's Disease

Chadwick, W., Brenneman, R., Martin, B., & Maudsley, S. R. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/604792 · Cited by 78 · see citing works

Characterization of AD-like phenotype in aged APPSwe/PS1dE9 mice

Huang, H., Nie, S., Cao, M., Marshall, C., Gao, J., Xiao, N., Hu, G., & Xiao, M. (2016) · AGE · doi:10.1007/s11357-016-9929-7 · Cited by 75 · see citing works

Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease

Aboukhatwa, M. A., Dosanjh, L. E., & Luo, Y. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-10 · Cited by 69 · see citing works

Episodic-like memory is sensitive to both Alzheimer's-like pathological accumulation and normal ageing processes in mice

Davis, K. E., Eacott, M. J., Easton, A., & Gigg, J. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.03.009 · Cited by 67 · see citing works

High tryptophan diet reduces CA1 intraneuronal β‐amyloid in the triple transgenic mouse model of Alzheimer’s disease

Noristani, H. N., Verkhratsky, A., & Rodriguez, J. J. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00845.x · Cited by 67 · see citing works

The amyloid precursor protein: a converging point in Alzheimer’s disease

Delport, A., & Hewer, R. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02863-x · Cited by 48 · see citing works

Gonadotropin-Releasing Hormone Receptor System: Modulatory Role in Aging and Neurodegeneration

Wang, L., Chadwick, W., Park, S. S., Zhou, Y., Silver, N., Martin, B., & Maudsley, S. R. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710793361559 · Cited by 65 · see citing works

Ultrasound-Excited Protoporphyrin IX-Modified Multifunctional Nanoparticles as a Strong Inhibitor of Tau Phosphorylation and β-Amyloid Aggregation

Xu, M., Zhou, H., Liu, Y., Sun, J., Xie, W., Zhao, P., & Liu, J. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b08230 · Cited by 65 · see citing works

Effect of escitalopram on Aβ levels and plaque load in an Alzheimer mouse model

Cirrito, J. R., Wallace, C. E., Yan, P., Davis, T. A., Gardiner, W. D., Doherty, B. M., King, D., Yuede, C. M., Lee, J.-M., & Sheline, Y. (2020) · Neurology · doi:10.1212/wnl.0000000000010733 · Cited by 61 · see citing works

Serotonin 6 receptor controls alzheimer’s disease and depression

Yun, H.-M., Park, K.-R., Kim, E.-C., Kim, S., & Hong, J. T. (2015) · Oncotarget · doi:10.18632/oncotarget.5777 · Cited by 62 · see citing works

APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD)

Lalonde, R., Fukuchi, K., & Strazielle, C. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.02.011 · Cited by 62 · see citing works

Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer’s disease

Gatta, E., Lefebvre, T., Gaetani, S., Santos, M. D., Marrocco, J., Mir, A., Cassano, T., Maccari, S., Nicoletti, F., & Mairesse, J. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.006 · Cited by 59 · see citing works

Fluoxetine protects against amyloid-beta toxicity, in part via daf-16 mediated cell signaling pathway, in Caenorhabditis elegans

Keowkase, R., Aboukhatwa, M. A., & Luo, Y. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.04.008 · Cited by 58 · see citing works

Escitalopram attenuates β-amyloid-induced tau hyperphosphorylation in primary hippocampal neurons through the 5-HT1A receptor mediated Akt/GSK-3β pathway

Wang, Y.-J., Ren, Q.-G., Gong, W.-G., Wu, D., Tang, X., Li, X.-L., Wu, F., Bai, F., Xu, L., & Zhang, Z.-J. (2016) · OncoTarget · doi:10.18632/oncotarget.7798 · Cited by 55 · see citing works

Impaired Adaptive Cellular Responses to Oxidative Stress and the Pathogenesis of Alzheimer's Disease

Texel, S. J., & Mattson, M. P. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3569 · Cited by 56 · see citing works

Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer’s disease

Reddy, A. P., Yin, X., Sawant, N. A., & Reddy, P. H. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab054 · Cited by 55 · see citing works

Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice

Stagni, F., Giacomini, A., Guidi, S., Ciani, E., Ragazzi, E., Filonzi, M., IASIO, R. D., Rimondini, R., & Bartesaghi, R. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.12.005 · Cited by 53 · see citing works

Limited impact of social isolation on Alzheimer-like symptoms in a triple transgenic mouse model.

Pietropaolo, S., Sun, Y., Li, R., Brana, C., Feldon, J., & Yee, B. K. (2009) · Behavioral Neuroscience · doi:10.1037/a0013607 · Cited by 54 · see citing works

Acute kidney injury-associated delirium: a review of clinical and pathophysiological mechanisms

Pang, H., Kumar, S., Ely, E. W., Gezalian, M. M., & Lahiri, S. (2022) · Critical Care · doi:10.1186/s13054-022-04131-9 · Cited by 54 · see citing works

Depressive symptoms, antidepressant use, and future cognitive health in postmenopausal women: the Women's Health Initiative Memory Study

Goveas, J. S., Hogan, P. E., Kotchen, J. M., Smoller, J. W., Denburg, N. L., Manson, J. E., Tummala, A., Mysiw, W. J., Ockene, J. K., Woods, N. F., et al. (2012) · International Psychogeriatrics · doi:10.1017/s1041610211002778 · Cited by 52 · see citing works

Paroxetine Attenuates Chondrocyte Pyroptosis and Inhibits Osteoclast Formation by Inhibiting NF-κB Pathway Activation to Delay Osteoarthritis Progression

Zheng, X., Qiu, J., Gao, N., Jiang, T., Li, Z., Zhang, W., Gong, Y., Hong, Z., & Hong, H. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s417598 · Cited by 51 · see citing works

Cognitive and emotional alterations in young Alzheimer's disease (3xTgAD) mice: Effects of neonatal handling stimulation and sexual dimorphism

Cañete, T., Blázquez, G., Tobeña, A., Giménez‐Llort, L., & Fernández‐Teruel, A. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.11.004 · Cited by 50 · see citing works

Pharmacological Treatment of Depression in Alzheimer’s Disease: A Challenging Task

Cassano, T., Calcagnini, S., Carbone, A., Bukke, V. N., Orkisz, S., Villani, R., Romano, A., Avolio, C., & Gaetani, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01067 · Cited by 43 · see citing works

Disrupting Self-Assembly and Toxicity of Amyloidogenic Protein Oligomers by “ Molecular Tweezers” - from the Test Tube to Animal Models

Attar, A., & Bitan, G. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990496 · Cited by 48 · see citing works

The role of synaptic activity in the regulation of amyloid beta levels in Alzheimer's disease

Cheng, X., Wu, J., Geng, M., & Xiong, J. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.021 · Cited by 48 · see citing works

Specific Serotonergic Denervation Affects tau Pathology and Cognition without Altering Senile Plaques Deposition in APP/PS1 Mice

Ramos‐Rodríguez, J. J., Gil, S. M., Rey-Brea, R., Berrocoso, E., & Garcı́a-Alloza, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079947 · Cited by 47 · see citing works

Effects of corticosterone and amyloid-beta on proteins essential for synaptic function: Implications for depression and Alzheimer's disease

Wuwongse, S., Cheng, S. S., Wong, G. T.-H., Hung, C. H.-L., Zhang, N. Q., Ho, J. Y. S., Law, A. C.-K., & Chang, R. C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.07.022 · Cited by 44 · see citing works

Antidepressant Use and Cognitive Outcomes in Very Old Women

Leng, Y., Diem, S. J., Stone, K. L., & Yaffe, K. S. (2017) · The Journals of Gerontology Series A · doi:10.1093/gerona/glx226 · Cited by 46 · see citing works

Translational Assays for Assessment of Cognition in Rodent Models of Alzheimer’s Disease and Dementia

Shepherd, A. L., Tyebji, S., Hannan, A. J., & Burrows, E. L. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0837-1 · Cited by 42 · see citing works

Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer’s disease

Metaxas, A., Anzalone, M., Vaitheeswaran, R., Petersen, S., Landau, A. M., & Finsen, B. R. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0491-2 · Cited by 42 · see citing works

Impaired Spatial Reorientation in the 3xTg-AD Mouse Model of Alzheimer’s Disease

Stimmell, A. C., Baglietto‐Vargas, D., Moseley, S. C., Lapointe, V., Thompson, L. M., LaFerla, F. M., McNaughton, B. L., & Wilber, A. A. (2019) · Scientific Reports · doi:10.1038/s41598-018-37151-z · Cited by 42 · see citing works

Antidepressants in Alzheimer’s Disease: A Focus on the Role of Mirtazapine

Correia, A. S., & Vale, N. (2021) · Pharmaceuticals · doi:10.3390/ph14090930 · Cited by 37 · see citing works

Investigation of Anxiety- and Depressive-like Symptoms in 4- and 8-Month-Old Male Triple Transgenic Mouse Models of Alzheimer’s Disease

Várkonyi, D., Török, B., Sipos, E., Fazekas, C. L., Bánrévi, K., Correia, P., Chaves, T., Farkas, S., Szabó, A., Martínez‐Bellver, S., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810816 · Cited by 41 · see citing works

Changes in tau phosphorylation levels in the hippocampus and frontal cortex following chronic stress

Yang, C., Guo, X.-L., Wang, G. H., Wang, H., Liu, Z. C., Liu, H., Zhu, Z., & Li, Y. (2014) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20133275 · Cited by 40 · see citing works

Citalopram Attenuates Tau Hyperphosphorylation and Spatial Memory Deficit Induced by Social Isolation Rearing in Middle-Aged Rats

Ren, Q., Gong, W.-G., Wang, Y., Zhou, Q.-D., & Zhang, Z. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0475-4 · Cited by 40 · see citing works

Excess tau PET ligand retention in elderly patients with major depressive disorder

Moriguchi, S., Takahata, K., Shimada, H., Kubota, M., Kitamura, S., Kimura, Y., Tagai, K., Tarumi, R., Tabuchi, H., Meyer, J. H., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0766-9 · Cited by 40 · see citing works

Anatomical and neurochemical organization of the serotonergic system in the mammalian brain and in particular the involvement of the dorsal raphe nucleus in relation to neurological diseases

Steinbusch, H. W. M., Dolatkhah, M. A., & Hopkins, D. A. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.02.003 · Cited by 39 · see citing works

The plasma membrane redox system is impaired by amyloid β-peptide and in the hippocampus and cerebral cortex of 3xTgAD mice

Hyun, D. H., Mughal, M. R., Yang, H., Lee, J. H., Ko, E. J., Hunt, N. D., de Cabo, R., & Mattson, M. P. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.07.020 · Cited by 39 · see citing works

Citalopram restores short-term memory deficit and non-cognitive behaviors in APP/PS1 mice while halting the advance of Alzheimer's disease-like pathology

Zhang, Q., Yang, C., Liu, T., Liu, L., Li, F., Cai, Y., Lv, K., Li, X., Gao, J., Sun, D., et al. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.021 · Cited by 39 · see citing works

Inhibition of acid sphingomyelinase reduces reactive astrocyte secretion of mitotoxic extracellular vesicles and improves Alzheimer’s disease pathology in the 5xFAD mouse

Crivelli, S. M., Quadri, Z., Vekaria, H. J., Zhu, Z., Tripathi, P., Elsherbini, A. M., Zhang, L., Sullivan, P. G., & Bieberich, E. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01633-7 · Cited by 39 · see citing works

Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease

Smith, G. S., Kramer, E., Ma, Y., Hermann, C. R., DHAWAN, V. M., Chaly, T., & Eidelberg, D. (2009) · Brain · doi:10.1093/brain/awn326 · Cited by 38 · see citing works

Behavioural Phenotyping of APPswe/PS1δE9 Mice: Age-Rrelated Changes and Effect of Long-Term Paroxetine Treatment

Olesen, L. Ø., Bouzinova, E. V., Severino, M., Sivasaravanaparan, M., Hasselstrøm, J. B., Finsen, B. R., & Wiborg, O. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165144 · Cited by 37 · see citing works

Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study

Noristani, H. N., Meadows, R. S., Olabarria, M., Verkhratsky, A., & Rodríguez, J. J. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.79 · Cited by 36 · see citing works

Serum amyloid β protein in young and elderly depression: a pilot study

Kita, Y., Baba, H., Maeshima, H., Nakano, Y., Suzuki, T., & Arai, H. (2009) · Psychogeriatrics · doi:10.1111/j.1479-8301.2009.00293.x · Cited by 34 · see citing works

Review of Advanced Drug Trials Focusing on the Reduction of Brain Beta-Amyloid to Prevent and Treat Dementia

Decourt, B., Noorda, K., Noorda, K. J., Shi, J., & Sabbagh, M. N. (2022) · Journal of Experimental Pharmacology · doi:10.2147/jep.s265626 · Cited by 32 · see citing works

Defects in Tongue Papillae and Taste Sensation Indicate a Problem with Neurotrophic Support in Various Neurological Diseases

Gardiner, J. C., Barton, D., Vanslambrouck, J. M., Braet, F., Hall, D. H., Marc, J., & Overall, R. L. (2007) · The Neuroscientist · doi:10.1177/1073858407312382 · Cited by 30 · see citing works

Effects of environmental manipulations in genetically targeted animal models of affective disorders

Renoir, T., Pang, T. Y., & Hannan, A. J. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.04.003 · Cited by 31 · see citing works

Beta-amyloid short- and long-term synaptic entanglement

Lanni, C., Fagiani, F., Racchi, M., Preda, S., Pascale, A., Grilli, M., Allegri, N., & Govoni, S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.018 · Cited by 29 · see citing works

Positron emission tomography imaging of serotonin degeneration and beta-amyloid deposition in late-life depression evaluated with multi-modal partial least squares

Smith, G. S., Workman, C. I., Protas, H. D., Su, Y., Savonenko, A. V., Kuwabara, H., Gould, N. F., Kraut, M. A., Joo, J. H., Nandi, A., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01539-9 · Cited by 29 · see citing works

Multicenter, randomized, placebo‐controlled, double‐blind clinical trial of escitalopram on the progression‐delaying effects in Alzheimer's disease

Choe, Y. M., Kim, K. W., Jhoo, J. H., Ryu, S. H., Seo, E. H., Sohn, B. K., Byun, M. S., Bak, J., Lee, J., Yun, H. J., et al. (2015) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4384 · Cited by 29 · see citing works

Effects of amyloid-β peptides on the serotoninergic 5-HT1A receptors in the rat hippocampus

Verdurand, M., Bérod, A., Bars, D. L., & Zimmer, L. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.01.008 · Cited by 29 · see citing works

Citalopram Ameliorates Impairments in Spatial Memory and Synaptic Plasticity in Female 3xTgAD Mice

Zhang, W., Junhong, G., Niu, X., Jie, W., Zhaojun, W., Meina, W., Yang, W., Zhang, J., & Qi, J. (2017) · BioMed Research International · doi:10.1155/2017/1238687 · Cited by 28 · see citing works

Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice

Ai, P.-H., Chen, S., Liu, X.-D., Zhu, X.-N., Pan, Y.-B., Feng, D.-F., Chen, S.-D., Xu, N.-J., & Sun, S.-Y. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00194-2 · Cited by 27 · see citing works

P2‐038: Preventive effects of a neurotrophic compound on cognition and pathology in 3xTg‐AD transgenic mouse model of Alzheimer's disease

Baazaoui, N., & Iqbal, K. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.06.574

Comorbid depression in Alzheimer’s disease (AD): novel observations from a longitudinal study in the triple-transgenic mouse model

Lavecchia, A. M., Romano, A., GAETANI, S., Pace, L., & Cassano, T. (2015) · IRIS Research product catalog (Sapienza University of Rome)

Prolonged running, not fluoxetine treatment, increases neurogenesis, but does not alter neuropathology, in the 3xTg mouse model of Alzheimer’s disease

Marlatt, M. W., Potter, M. C., Bayer, T. A., van Praag, H., & Lucassen, P. J. (2013) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2012_237 · Cited by 92 · see citing works

The Effects of a Novel Anti-inflammatory on Behavioral Tests of Cognition and Anxiety in a Mouse Model of Alzheimer’s Disease

Rauhuff, H., Gill, W. D., Shelton, H. W., Kerns, C. W., Gabbita, S. P., & Brown, R. W. (2019) · Digital Commons - East Tennessee State University (East Tennessee State University)